Information by business segment
Tobacco business
Pharmaceutical business
Clinical development of pharmaceuticals
FY 2023
Clinical Development (as of October 31, 2023)
Clinical Development (as of July 31, 2023)
Clinical Development (as of May 2, 2023)
FY 2022
Clinical Development (as of February 14, 2023)
Clinical Development (as of October 31, 2022)
Clinical Development (as of July 29, 2022)
Clinical Development (as of April 28, 2022)
FY 2021
Clinical Development (as of February 14, 2022)
Clinical Development (as of October 29, 2021)
Clinical Development (as of July 30, 2021)
Clinical Development (as of April 30, 2021)
FY 2020
Clinical Development (as of February 9, 2021)
Clinical Development (as of October 30, 2020)
Clinical Development (as of July 31, 2020)
Clinical Development (as of April 30, 2020)
FY 2019
Clinical Development (as of February 6, 2020)
Clinical Development (as of October 31, 2019)
Clinical Development (as of July 31, 2019)
Clinical Development (as of April 26, 2019)
FY 2018
Clinical Development (as of February 7, 2019)
Clinical Development (as of October 31, 2018)
Clinical Development (as of August 1, 2018)
Clinical Development (as of May 1, 2018)
FY 2017
Clinical Development (as of February 6, 2018)
Clinical Development (as of November 1, 2017)
Clinical Development (as of August 2, 2017)
Clinical Development (as of May 10, 2017)
FY 2016
Clinical Development (as of February 6, 2017)
Clinical Development (as of October 31, 2016)
Clinical Development (as of August 1, 2016)
Clinical Development (as of May 2, 2016)
Related links
Results and reports
Results and forecasts
Investor presentations
Integrated report
Information by business segment
Home
Investors
Results and reports
Information by business segment